[1]贾自晓.血清抗环瓜氨酸肽抗体、25-羟维生素D、基质金属蛋白酶-2和基质金属蛋白酶-9对类风湿性关节炎患者骨侵蚀的预测价值[J].新乡医学院学报,2023,40(10):932-936.[doi:10.7683/xxyxyxb.2023.10.005]
　JIA Zixiao.Predictive value of serum anti-cyclic citrullinated peptide antibody,25-hydroxyvitamin D,matrix metalloproteinase-2 and matrix metalloproteinase-9 for bone erosion in patients with rheumatoid arthritis[J].Journal of Xinxiang Medical University,2023,40(10):932-936.[doi:10.7683/xxyxyxb.2023.10.005]
点击复制

血清抗环瓜氨酸肽抗体、25-羟维生素D、基质金属蛋白酶-2和基质金属蛋白酶-9对类风湿性关节炎患者骨侵蚀的预测价值
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年10
页码:
932-936
栏目:
临床研究
出版日期:
2023-10-05

文章信息/Info

Title:
Predictive value of serum anti-cyclic citrullinated peptide antibody,25-hydroxyvitamin D,matrix metalloproteinase-2 and matrix metalloproteinase-9 for bone erosion in patients with rheumatoid arthritis
作者:
贾自晓
（通许第一医院检验科，河南　通许　475400）
Author(s):
JIA Zixiao
（Department of Clinical Laboratory,Tongxu First Hospital,Tongxu 475400,Henan Province,China）
关键词:
类风湿性关节炎; 骨侵蚀; 抗环瓜氨酸肽抗体; 25-羟维生素D; 基质金属蛋白酶-2; 基质金属蛋白酶-9
Keywords:
rheumatoid arthritis; bone erosion; anti-cyclic citrullinated peptide antibody; 25-hydroxyvitamin D; matrix metalloproteinase-2; matrix metalloproteinase-9
分类号:
R593.22
DOI:
10.7683/xxyxyxb.2023.10.005
文献标志码:
A
摘要:
目的　探讨血清抗环瓜氨酸肽（CCP）抗体、25-羟维生素D［25-(OH)D］、基质金属蛋白酶（MMP）-2、MMP-9水平对类风湿性关节炎（RA）患者骨侵蚀的预测价值。
方法　选择2019年1月至2022年1月通许第一医院收治的83例RA患者为研究对象。所有患者入组后给予非甾体抗炎药双氯芬酸钠缓释胶囊（每粒 25 mg），口服，每日3次，每次1粒，连续用药4周。于治疗前，设计基线资料调查表，记录患者的性别、年龄、病程、疾病类型、晨僵时间、受累关节数目等一般资料。所有患者完成4周药物治疗后接受X线检查评估骨侵蚀情况，根据X线检查结果将患者分为骨侵蚀组（n=44）和非骨侵蚀组（n=39）。治疗前采用酶联免疫吸附法检测患者血清中MMP-2、MMP-9、抗CCP抗体、25-(OH)D水平，采用流式细胞术检测患者外周血中辅助性T细胞17（Th17）水平。采用logistic回归分析RA患者治疗后骨侵蚀发生的危险因素；绘制受试者操作特征（ROC）曲线分析血清MMP-2、MMP-9、抗CCP抗体、25-(OH)D水平对RA患者治疗后骨侵蚀发生的预测价值。
结果　骨侵蚀组患者的血清MMP-2、MMP-9、抗CCP抗体水平显著高于非骨侵蚀组，25-(OH)D水平显著低于非骨侵蚀组（P<0.05）。骨侵蚀组与非骨侵蚀组患者的年龄、性别、病程、疾病类型、晨僵时间、受累关节数目及Th17水平比较差异无统计学意义（P>0.05）。Logistic回归分析结果显示，血清MMP-2、MMP-9、抗CCP抗体过表达和25-(OH)D低表达是RA患者治疗后发生骨侵蚀的危险因素（P<0.05）。ROC曲线分析显示，血清MMP-2、MMP-9、抗CCP抗体、25-(OH)D水平预测RA患者治疗后发生骨侵蚀的截断值分别为493.979 ng·L-1、400.554 ng·L-1、0.18 Ru·L-1、28.885 μg·L-1，曲线下面积分别为0.813、0.809、0.852、0.867。
结论　血清MMP-2、MMP-9、抗CCP抗体过表达及25-(OH)D低表达是RA患者非甾体抗炎药治疗后发生骨侵蚀的危险因素，血清抗CCP抗体、25-(OH)D、MMP-2、MMP-9水平对RA患者非甾体抗炎药治疗后骨侵蚀的发生有一定预测价值。
Abstract:
Objective　To investigate the predictive value of serum anti-cyclic citrullinated peptide (CCP) antibody,25-hydroxyvitamin D［25-(OH)D］,matrix metalloproteinase (MMP)-2 and MMP-9 for bone erosion in patients with rheumatoid arthritis (RA).
Methods　A total of 83 RA patients admitted to Tongxu First Hospital from January 2019 to January 2022 were selected as the research subjects.After enrollment,all patients were given the non-steroidal anti-inflammatory drug diclofenac sodium sustained-release capsules(25 mg per capsule) orally,three times a day,one capsule each time,for four consecutive weeks.Before treatment,a baseline data questionnaire was designed to record general information such as the patient′s gender,age,course of disease,disease type,time of morning stiffness and number of affected joints.After completing 4 weeks of medication treatment,all patients underwent X-ray examination to evaluate their bone erosion status.Based on the X-ray examination results,the patients were divided into bone erosion group（n=44） and non-bone erosion group（n=39）.Before treatment,serum levels of MMP-2,MMP-9,anti-CCP antibody and 25-(OH) D were measured by enzyme-linked immunosorbent assay,and peripheral blood helper T cell 17 (Th17) level was measured by flow cytometry.The risk factors for bone erosion in RA patients after treatment were analyzed by logistic regression analysis;the predictive value of serum MMP-2,MMP-9,anti-CCP antibody and 25-(OH) D levels on the occurrence of bone erosion in RA patients after treatment was analyzed by receiver operating characteristic (ROC) curve.
Results　The serum levels of MMP-2,MMP-9 and anti CCP antibody of patients in the bone erosion group were significantly higher than those in the non-bone erosion group (P<0.05),and the level of 25-(OH) D was significantly lower than that in the non-bone erosion group (P<0.05).There was no significant difference in age,gender,course of disease,disease type,morning stiffness time,number of affected joints and Th17 level of patients between the bone erosion group and the non-bone erosion group (P>0.05).The results of logistic regression analysis showed that overexpression of serum MMP-2,MMP-9,anti-CCP antibody and low expression of 25-(OH) D were risk factors for bone erosion in RA patients after treatment (P<0.05).ROC curve analysis showed that the cutoff values of serum MMP-2,MMP-9,anti-CCP antibody and 25-(OH)D levels predicting bone erosion in RA patients after treatment were 493.979 ng · L-1, 400.554 ng · L-1,0.18 Ru · L-1 and 28.885 μg· L-1,respectively;the area under the curve were 0.813,0.809,0.852 and 0.867,respectively.
Conclusion　Overexpression of serum MMP-2,MMP-9,anti-CCP antibody,and low expression of 25-(OH)D are risk factors for bone erosion in RA patients after non-steroidal anti-inflammatory drug treatment;serum anti-CCP antibody,25-(OH)D,MMP-2 and MMP-9 levels have certain predictive value for the occurrence of bone erosion in RA patients after non-steroidal anti-inflammatory drug treatment.

参考文献/References:

［1］　FIGUS F A，PIGA M，AZZOLIN I，et al.Rheumatoid arthritis:extra-articular manifestations and comorbidities［J］.Autoimmun Rev,2021,20(4):102776.
［2］　胡小丽，陈霞，黄霓，等.X线、高频超声、MRI检查对早期类风湿关节炎膝关节炎的诊断效能［J］.山东医药,2018,58(39):52-54.
HU X L,CHEN X,HUANG N,et al.The diagnostic efficacy of X-ray,high-frequency ultrasound and MRI in the early rheumatoid arthritis of knee arthritis［J］.Shandong Med J,2018,58 (39):52-54.
［3］　吴振彪，卢宁，王彦宏，等.基质金属蛋白酶MMP-2、MMP-9与类风湿性关节炎关节破坏的关系［J］.中国免疫学杂志,2006,22(3):260-262.
WU Z B,LU N,WANG Y H,et al.Association of serum MMP-2 and MMP-9 and progression of joint damage in early rheumatoid arthritis［J］.Chin J Immun,2006,22(3):260-262.
［4］　HOOVELS L V，JACOBS J，CRUYSSEN B V，et al.Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis［J］.Ann Rheum Dis，2018，77(5):667-677.
［5］　徐凤霞，陈飒利，胡小霞，等.25羟基维生素D3水平与类风湿关节炎的相关性分析［J］.检验医学与临床,2017,14(20):2989-2990.
XU F X,CHEN S L,HU X X,et al.Analysis on correlation between 25-(OH)D3 level with rheumatoid arthritis［J］.Lab Med Clin,2017,14(20):2989-2990.
［6］　高照猛，张磊.血清25-羟维生素D水平在非绝经期类风湿关节炎女性患者中的临床意义［J］.标记免疫分析与临床,2018,25(2):220-223.
GAO Z M,ZHANG L.Clinical significance of serum 25-hydroxyvitamin D level in non-menopausal women with rheumatoid arthritis［J］.Lab Immun Clin Med,2018,25(2):220-223.
［7］　中华医学会风湿病学分会.类风湿关节炎诊断及治疗指南［J］.中华风湿病学杂志,2010,14(4):265-270.
RHEUMATOLOGY BRANCH OF CHINESE MEDICAL ASSOCIATION.Guidelines for diagnosis and treatment of rheumatoid arthritis［J］.Chin J Rheumatol,2010,14(4):265-270.
［8］　MEEDNU N，ZHANG H，OWEN T，et al.A link between B cells and bone erosion in rheumatoid arthritis:receptor activator of nuclear factor kappa-B ligand production by memory B cells［J］.Arthritis Rheumatol,2016,68(4):805-816.
［9］　SCOTT D L.Radiological progression in established rheumatoid arthritis［J］.J Rheumatol Suppl,2004,69(31):55-65.
［10］　周琼竦.基质金属蛋白酶在类风湿性关节炎患者血清中的表达及意义［J］.现代仪器与医疗,2016,22(2):55-56,90.
ZHOU Q K.Expression and significance of matrix metalloproteinases in serum of patients with rheumatoid arthritis ［J］.Mod Instr,2016,22(2):55-56,90.
［11］　冯艳琴，姚忠红，程建明，等.鹿瓜多肽穴位注射结合电针对类风湿关节炎类风湿因子及 基质金属蛋白酶的影响［J］.中国中医急症,2016,25(6):1185-1188.
FENG Y Q,YAO Z H,CHENG J M,et al.Effect of acupoint injection combined with electro acupuncture on rheumatoid arthritis aheumatoid factor and matrix metalloproteinases in rheumatoid arthritis［J］.J Emerg Tradit Chin Med,2016,25(6):1185-1188.
［12］　陆学丹，余学芳.血清基质金属蛋白酶2和凝血功能指标在类风湿性关节炎病情活动度监测中的意义［J］.安徽医学,2019,40(11):1230-1232.
LU X D,YU X F.Significance of serum matrix metalloproteinase 2 and coagulation function indexes in monitoring disease activity in rheumatoid arthritis［J］.Anhui Med J,2019,40(11):1230-1232.
［13］　安晓蓓，刘进子，付素兰，等.地藤痹痛颗粒治疗类风湿关节炎疗效评价及对血清基质金属蛋白酶-3、9的影响［J］.世界中西医结合杂志,2019,14(5):683-687.
AN X B,LIU J Z,FU S L,et al.Therapeutic effects of diteng bitong granules on rheumatoid arthritis and its influence on serum matrix metalloproteinase-3 and 9 ［J］.World J Integrat Trad Western Med,2019,14(5):683-687.
［14］　廖卓君，徐建华，徐胜前，等.类风湿关节炎患者外周血Th17的变化及与疾病活动性和骨侵蚀的关系［J］.安徽医科大学学报,2010,45(5):663-667.
LIAO Z J,XU J H,XU S Q,et al.Variation of Th17 cells in the peripheral blood of rheumatoid arthritis patients and their relationship with disease activity and bone erosion［J］.Acta Univ Med Anhui,2010,45(5):663-667.
［15］　LI C，ZHANG Y，SONG H，et al.Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis［J］.Chin Med J (Engl),132(24):2899-2904.
［16］　张玉慧，宋为民，孙莉，等.类风湿关节炎患者血清25羟维生素D水平及相关因素分析［J］.中国医药导报,2019,16(5):142-145.
ZHANG Y H,SONG W M,SUN L,et al.Analysis of serum 25-hydroxyvitamin D levels in patients with rheumatoid arthritis and its related factors［J］.Chin Med Herald,2019,16(5):142-145.
［17］　SULAIMAN F N,WONG K K,AHMAD W A W,et al.Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients［J］.Medicine (Baltimore),2019,98(12):e14945.
［18］　STROPUVIEN S，BARANAUSKAIT A，BUKAUSKIEN L，et al.The impact of anti-cyclic citrullinated peptide antibody status on the management of patients with early rheumatoid arthritis:observational study results from Lithuania［J］.Acta Med Litu,2018,25(2):112-123.
［19］　QUINTANA-DUQUE M A，CAMINOS J E，VARELA- NARI N~O A，et al.The role of 25-hydroxyvitamin D as a predictor of clinical and radiological outcomes in early onset rheumatoid arthritis［J］.J Clin Rheumatol,2017,23(1):33-39.
［20］　WONG T H，GUPTA E D，RADHAKRISHNAN A K，et al.Effects of 25-hydroxyvitamin D and vitamin D-binding protein on bone mineral density and disease activity in malaysian patients with rheumatoid arthritis［J］.Int J Rheum Dis,2018,21(5):992-1000.

相似文献/References:

[1]高倩综述,武永康审校.自身抗体检测在类风湿性关节炎中的应用研究[J].新乡医学院学报,2011,28(02):252.
[2]岳燕,潘丽丽,崔丽,等.辅助性T细胞9相关细胞因子在类风湿性关节炎患者血清中的表达[J].新乡医学院学报,2012,29(11):837.
[3]张　兵,杨　林,徐海斌.非化脓性关节炎患者血清及关节滑膜中炎性介质的表达及其与Ｃ反应蛋白的相关性[J].新乡医学院学报,2015,32(09):877.
[4]雷　震.3种麻醉方法在类风湿性关节炎患者全膝关节置换术中的应用效果比较[J].新乡医学院学报,2016,33(12):1074.[doi:10.7683/xxyxyxb.2016.12.015]
　LEI Zhen.Comparison of the effect of three anesthesia for total knee replacement in patients with rheumatoid arthritis[J].Journal of Xinxiang Medical University,2016,33(10):1074.[doi:10.7683/xxyxyxb.2016.12.015]
[5]王婷婷,单　超,赵　今.白细胞介素-17基因多态性与牙周炎和类风湿性关节炎相关性研究进展[J].新乡医学院学报,2020,37(5):498.[doi:10.7683/xxyxyxb.2020.05.023]

更新日期/Last Update: 2023-10-05